# Adherence to Treatment With PegIntron Pen Plus Rebetol in Treatment-naïve Adult Patients With Hepatitis C in Romania (Study P04247)

> **NCT00705107** · — · TERMINATED · sponsor: **Merck Sharp & Dohme LLC** · enrollment: 267 (actual)

## Conditions studied

- Hepatitis C, Chronic
- Hepatitis C

## Interventions

- **BIOLOGICAL:** PegIntron pen (peginterferon alfa-2b; SCH 54031)
- **DRUG:** Rebetol (ribavirin; SCH 18908)

## Key facts

- **NCT ID:** NCT00705107
- **Lead sponsor:** Merck Sharp & Dohme LLC
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** TERMINATED
- **Start date:** 2004-11
- **Primary completion:** 2007-11
- **Final completion:** 2007-11
- **Target enrollment:** 267 (ACTUAL)
- **Last updated:** 2015-06-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00705107

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00705107, "Adherence to Treatment With PegIntron Pen Plus Rebetol in Treatment-naïve Adult Patients With Hepatitis C in Romania (Study P04247)". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00705107. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*